L

Lava Therapeutics B.V.

77 employees

Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
biotechnology
gamma delta T cells
Medical
bispecific antibodies
oncology
Life Science

Date founded

2016

Funding rounds raised

Total raised

$83M

from 9 investors over 9 rounds

L

Lava Therapeutics B.V. raised $83M on September 17, 2020

Investors: Pureos Bioventures, Sanofi Ventures, Versant Ventures, Gilde Healthcare, Ysios Capital and Redmile Group

L

Lava Therapeutics B.V. raised $19M on May 23, 2018

Investors: Kinled Holding Ltd, Gilde Healthcare and Versant Ventures

FAQ